Abstract:Objective: Lower extremity computed tomography angiography (CTA) is frequently used for anatomic assessment of lower extremity peripheral arterial disease. When lower extremity bypass is planned, duplex ultrasound (DUS) is routinely obtained to evaluate the great saphenous vein (GSV) for use as conduit. Although GSV can be visualized on CTA images, diameter assessment is not routinely included in formal study interpretation. We hypothesized that CTA images could be used to measure GSV diameters and that CTA-based diameters would correlate with measurements obtained using DUS. Methods: Consecutive patients undergoing lower extremity arterial bypass who were evaluated preoperatively with both CTA and DUS vein mapping were identified at a single hospital. Minimum aboveand below-knee GSV diameters were measured from electronically archived CTA images by two independent observers. CTAs were performed using standard arterial phase protocol without additional venous phase imaging. Between-observer reproducibility of CTA-based diameter measurements was evaluated using intraclass correlation coefficients. Correlation between CTA and DUS-based GSV diameters was evaluated with Spearman correlation coefficients. CTA diameter cut-points for identification of adequate GSV bypass conduit, defined as DUS-based minimum GSV diameter > 3 mm, were determined using receiver-operating characteristic curves. Results: Sixty-three lower extremities were evaluated in 36 patients. In the absence of previous surgical removal, GSV was visible on all CTAs reviewed. No instances of GSV thrombosis were identified on DUS. Minimum DUS-based above-knee GSV diameter was 2.9 0.1 mm (range, 1.4-4.6 mm), and mean below-knee diameter was 2.6 0.1 mm (range, 1.3-4.0 mm). When GSV was visible and exceeded the minimum diameter threshold for CTA measurement, correlation between CTAand DUS-based diameters was both positive and highly significant ( 0.595; P < .0001). CTA-based diameters also had excellent reliability between observers (r [95% CI]: 0.88 [0.85-0.91]). For identification of adequate bypass conduit using CTA, above-knee GSV diameter > 3.9 mm was 67% sensitive and 73% specific; below-knee GSV diameter >3.0 mm was 75% sensitive and 84% specific. Conclusions: CTA-based GSV diameter measurements have good reproducibility and highly significant correlation with DUS-based diameters. CTA-based GSV diameter is a specific but relatively insensitive indicator of adequate bypass conduit. When CTA-based diameters indicate inadequate GSV bypass conduit, confirmatory DUS vein mapping is warranted. Confirmatory DUS vein mapping may be unnecessary when adequate vein diameter is identified on CTA. (J Vasc Surg 2013;57:50-5.)

Glycyl-tRNA sequestration is a unifying mechanism underlying GARS1-associated peripheral neuropathy

Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis

Charcot–Marie–Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect

Aberrant GlyRS-HDAC6 Interaction Linked to Axonal Transport Deficits in Charcot-Marie-Tooth Neuropathy

CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase

Alternative stable conformation capable of protein misinteraction links tRNA synthetase to peripheral neuropathy.

Impaired protein translation in Drosophila models for Charcot–Marie–Tooth neuropathy caused by mutant tRNA synthetases

SIRT2-knockdown Rescues GARS-induced Charcot-Marie-Tooth Neuropathy

Charcot-Marie-Tooth–Linked Mutant GARS Is Toxic to Peripheral Neurons Independent of Wild-Type GARS Levels

Loss of seryl-tRNA synthetase (SARS1) causes complex spastic paraplegia and cellular senescence

Insights into phenotypic variability caused by GARS1 pathogenic variants

The role of tRNA synthetases in neurological and neuromuscular disorders

From the Southern Association for Vascular Surgery Computed tomography angiography-based evaluation of great saphenous vein conduit for lower extremity bypass

Charcot–Marie–Tooth mutation in glycyl-tRNA synthetase stalls ribosomes in a pre-accommodation state and activates integrated stress response

Drosophila Models for Charcot–Marie–Tooth Neuropathy Related to Aminoacyl-tRNA Synthetases

Biallelic variants in ARHGAP19 cause a motor-predominant neuropathy with asymmetry and conduction slowing

Tyrosyl-tRNA synthetase has a noncanonical function in actin bundling

A missense, loss-of-function YARS1 variant in a patient with proximal-predominant motor neuropathy

A previously unreported NARS1 variant causes dominant distal hereditary motor neuropathy in a French family

Hearing Impairment-Associated KARS Mutations Lead to Defects in Aminoacylation of Both Cytoplasmic and Mitochondrial Trna Lys

Antitrypanosomal activity & docking studies of isolated constituents from the lichen Cetraria islandica: possibly multifunctional scaffolds.